Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 179.52M
March 31, 2026 132.71M
December 31, 2025 136.66M
September 30, 2025 124.20M
June 30, 2025 117.07M
March 31, 2025 159.40M
December 31, 2024 178.75M
September 30, 2024 193.52M
June 30, 2024 184.74M
March 31, 2024 173.19M
December 31, 2023 139.49M
September 30, 2023 130.25M
June 30, 2023 126.68M
March 31, 2023 104.65M
December 31, 2022 115.20M
September 30, 2022 92.70M
June 30, 2022 102.44M
March 31, 2022 103.95M
December 31, 2021 79.85M
September 30, 2021 98.06M
June 30, 2021 82.87M
March 31, 2021 38.76M
December 31, 2020 39.23M
September 30, 2020 28.38M
June 30, 2020 13.12M
Date Value
March 31, 2020 58.36M
December 31, 2019 60.36M
September 30, 2019 57.93M
June 30, 2019 53.34M
March 31, 2019 43.71M
December 31, 2018 34.36M
September 30, 2018 27.23M
June 30, 2018 6.831M
March 31, 2018 -5.744M
December 31, 2017 -1.481M
September 30, 2017 -0.869M
June 30, 2017 15.14M
March 31, 2017 15.31M
December 31, 2016 8.744M
September 30, 2016 4.188M
June 30, 2016 -10.38M
March 31, 2016 -13.70M
December 31, 2015 -13.51M
September 30, 2015 -15.39M
June 30, 2015 -4.644M
March 31, 2015 4.569M
December 31, 2014 4.55M
September 30, 2014 -11.21M
June 30, 2014 -29.24M
March 31, 2014 -48.96M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Viatris, Inc. 1.806B
Johnson & Johnson 22.61B
Liquidia Corp. 150.69M
Organon & Co. 558.00M
ANI Pharmaceuticals, Inc. 167.52M